Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension.

Varghese, Mathews Valuparampil; Niihori, Maki; Eccles, Cody A; Kurdyukov, Sergey; James, Joel; Rafikova, Olga; Rafikov, Ruslan

Varghese, Mathews Valuparampil; Niihori, Maki; Eccles, Cody A; Kurdyukov, Sergey; James, Joel; Rafikova, Olga; Rafikov, Ruslan.

Afiliación

Varghese MV; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Niihori M; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Eccles CA; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Kurdyukov S; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
James J; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Rafikova O; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Rafikov R; Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, AZ 85721, USA.

Antioxidants (Basel) ; 9(2)2020 Jan 25.

Article en En | MEDLINE | ID: mdl-31991719

Palabras clave

Akt; Pulmonary arterial hypertension; Warburg effect; anaplerosis; metabolism; nitroxide-conjugated peptide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Antioxidants (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google